Propionic Acidemia Therapeutic Market Size, Growth, and Strategic Insights 2026–2033 The Propionic Acidemia Therapeutic Market is witnessing significant evolution driven by advancements in genetic therapies and growing awareness of rare metabolic disorders. This market's growth is catalyzed by innovative treatment modalities and expanding patient diagnostics worldwide, reflecting shifting industry trends towards precision medicine and sustainable therapeutic development. Market Size and Overview The propionic acidemia therapeutic market is estimated to be valued at USD 648.7 Mn in 2025 and is expected to reach USD 1111.8 Mn by 2032, growing at a compound annual growth rate (CAGR) of 8.00% from 2025 to 2032. https://www.coherentmi.com/industry-reports/propionic-acidemia-therapeutic-market